Peter Tombros was born in 1942. He graduated from Penn State University with a B.S. in biology and an M.S. in economics. He obtained an M.B.A. from the Wharton School of Business at the University of Pennsylvania. Peter’s professional career includes eight years as president and chief executive officer of Enzon Pharma, taking the company from $44 million to more than $3 billion capitalization. He spent five years at Pfizer in a variety of positions, including vice president of marketing, executive vice president of Pfizer Pharmaceuticals and vice president of strategic
planning, where he oversaw the divestiture of non-healthcare businesses. Peter served as chief executive officer and director of VivoQuest from 2002 to 2005. He also was a director of Alpharma, Pharmanet Development Group and Dendrite International. Peter currently is on the board of Cambrex, Inc., Investigative Management Group, the Milton S. Hershey Medical Center and the Columbia University Medical Center Board of Advisors. Peter recently was appointed to the Commonwealth of Pennsylvania CURE Program, Health Research Advisory Committee. The Financial Times selected him to receive the 2015 Outstanding Director Award. Peter and his wife Ann created the Tombros Foundation in 2001 to pursue their philanthropic interests. They live in New Canaan. For recreation, Peter enjoys playing bridge.